The International Association of Trichologists says the review saw promise in short peptides for hair follicles, but most remain unproven.
Recap by typeshit. Post by @iatrichologists on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Nurturher Aesthetics points out retatrutide has not been FDA approved and explains why most providers are not taking it themselves.
Spierings explains why the placebo effect makes skincare hard to study, in a clip from the show's full collagen peptides episode.
Loading…